Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10856486 | 0.88 | MEN1 (0.70) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 | |
| SCHEMBL14552522 | 0.88 | MEN1 (0.69) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 | |
| SCHEMBL10655218 | 0.87 | MEN1 (0.69) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 | |
| SCHEMBL14552329 | 0.86 | SMN1; SMN2 (0.66) | MEN1KMT2ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL14552489 | 0.85 | KDM4E (0.70) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 | |
| SCHEMBL11010135 | 0.85 | MEN1 (0.69) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 | |
| SCHEMBL14552392 | 0.85 | MEN1 (0.66) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 | |
| SCHEMBL14552420 | 0.84 | MEN1 (0.83) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 | |
| SCHEMBL10654653 | 0.84 | MEN1 (0.64) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 | |
| SCHEMBL14552404 | 0.83 | MEN1 (0.64) | MEN1KMT2AHSD17B10SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130203895-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130203895-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130012620-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| US-20130012620-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| WO-2011116050-A2 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012620-A1 | CURING AGENTS FOR EPOXY RESINS | DOT1L, EHMT1, ASH1L | MEN1 3864/4885KMT2A 271/4885HSD17B10 2620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.